Serum trypsinogen activation peptide in the assessment of the diagnosis and severity of acute pancreatic damage: A pilot study using a new determination technique

Pancreas

Volumn 29, Issue 4, 2004, Pages 298-305

  Pezzilli, R ^a   Venturi, M ^b   Morselli Labate, A M ^a   Ceciliato, R ^a   Lamparelli, M G ^b   Rossi, A ^b   Moneta, D ^b   Piscitelli, L ^a   Corinaldesi, R ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b PFIZER INC   (United States)

Author keywords

Acute necrotizing pancreatitis; Diagnosis; Laboratory techniques and procedures; Pancreatitis; Severity of Illness Index; Trypsinogen

Indexed keywords

AMYLASE; TRIACYLGLYCEROL LIPASE; TRYPSINOGEN ACTIVATION PEPTIDE;

ABDOMINAL PAIN; ACUTE PANCREATITIS; ADULT; AGED; AMYLASE BLOOD LEVEL; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; ENDOSCOPY; FEMALE; HUMAN; MALE; PANCREAS INJURY; PRIORITY JOURNAL; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; URINE LEVEL;

ADULT; AGED; AGED, 80 AND OVER; AMYLASES; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; DIAGNOSTIC TECHNIQUES, ENDOCRINE; FEMALE; HUMANS; LIPASE; MALE; MIDDLE AGED; OLIGOPEPTIDES; PANCREATITIS; PILOT PROJECTS; SEVERITY OF ILLNESS INDEX;

EID: 13644258333     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-200411000-00009     Document Type: Article

References (50)

1. Uomo G, Pezzilli R, Cavallini G. Management of acute pancreatitis in clinical practice. ProInf-A.I.S.P. Study Group. Progetto Informatizzato Pancreatite Acuta-Associazione Italiana Studio Pancreas. Ital J Gastroenterol Hepatol. 1999;31:635-642.
2. Dervenis C, Smailis D, Hatzitheoklitos E. Bacterial translocation and its prevention in acute pancreatitis. J Hepatobiliary Pancreat Surg. 2003;10:415-418.
3. Neoptolemos JP, Carr-Locke DL, London NJ, et al. Controlled trial of urgent endoscopic retrograde cholangiopancreatography and endoscopic sphincterotomy versus conservative treatment for acute pancreatitis due to gallstones. Lancet. 1988;2:979-983.
4. Pezzilli R, Billi P, Barakat B, et al. Effects of early ductal decompression in human biliary acute pancreatitis. Pancreas. 1998;16:165-168.
5. Pezzilli R, Mancini F. Assessment of severity of acute pancreatitis: a comparison between old and most recent modalities used to evaluate this perennial problem. World J Gastroenterol. 1999;5:283-285.
6. Pezzilli R, Morselli-Labate AM, Barbieri AR, et al. Clinical usefulness of the serum carboxypeptidase B activation peptide in acute pancreatitis. JOP. 2000;1:58-68.
7. Gudgeon AM, Heath DI, Hurley P, et al. Trypsinogen activation peptides assay in the early prediction of severity of acute pancreatitis. Lancet. 1990;6:4-8.
8. Frossard JL. Trypsin activation peptide (TAP) in acute pancreatitis: from pathophysiology to clinical usefulness. JOP. 2001;2:69-77.
9. Kylanpaa-Back ML, Kemppainen E, Puolakkainen P. Trypsin-based laboratory methods and carboxypeptidase activation peptide in acute pancreatitis. JOP. 2002;3:34-48.
10. Kemppainen E, Mayer J, Puolakkainen P, et al. Plasma trypsinogen activation peptide in patients with acute pancreatitis. Br J Surg. 2001;88:679-680.
11. Lempinen M, Stenman UH, Puolakkainen P, et al. Sequential changes in pancreatic markers in acute pancreatitis. Scand J Gastroenterol. 2003;38:666-675.
12. Bradley EL. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, GA, September 11 through 13, 1992. Arch Surg. 1993;128:586-590.
13. Lamparelli MG, Castoldi R, Moneta D, et al. Development of a novel anti-TAP cross-species reactive immunoassay for the detection of acute pancreatitis. Pancreatology. 2004;4:166-167.
14. Lusted LB. Decision-making studies in patient management. N Engl J Med. 1971;284:416-424.
15. Robertson EA, Zweig MH. Use of receiver operating characteristic curves to evaluate the clinical performance of analytical systems. Clin Chem. 1981;27:1569-1574.
16. Pezzilli R, Billi P, Miniero R, et al. Serum interleukin-6, interleukin-8, and beta 2-microglobulin in early assessment of severity of acute pancreatitis. Comparison with serum C-reactive protein. Dig Dis Sci. 1995;40:2341-2348.
17. Ventrucci M, Pezzilli R, Gullo L, et al. Role of serum pancreatic enzyme assays in diagnosis of pancreatic disease. Dig Dis Sci. 1989;34:39-45.
18. Ventrucci M, Pezzilli R, Naldoni P, et al. Serum pancreatic enzyme behavior during the course of acute pancreatitis. Pancreas. 1987;2:506-509.
19. Steinberg WM. Predictors of severity of acute pancreatitis. Gastroenterol Clin North Am. 1990;19:849-861.
20. Agarwal N, Pitchumoni CS. Assessment of severity in acute pancreatitis. Am J Gastroenterol. 1991;86:1385-1391.
21. Mayer AD, McMahon MJ, Bowen M, et al. C Reactive protein: an aid to assessment and monitoring of acute pancreatitis. J Clin Pathol. 1984;37:207-211.
22. Leser HG, Gross V, Scheibenbogen C, et al. Elevation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis. Gastroenterology. 1991;101:782-785.
23. Uhl W, Buchler M, Malfertheiner P, et al. PMN-elastase in comparison with CRP, antiproteases, and LDH as indicators of necrosis in human acute pancreatitis. Pancreas. 1991;6:253-259.
24. Gross V, Andreesen R, Leser HG, et al. Interleukin-8 and neutrophil activation in acute pancreatitis. Eur J Clin Invest. 1992;22:200-203.
25. 2 in human acute pancreatitis. Gastroenterology. 1989;97:1521-1526.
26. Exley AR, Leese T, Holliday MP, et al. Endotoxaemia and serum tumour necrosis factor as prognostic markers in severe acute pancreatitis. Gut. 1992;33:1126-1128.
27. Pezzilli R, Billi P, Platè L, et al. Human pancreatic secretory trypsin inhibitor in the assessment of the severity of acute pancreatitis. A comparison with C-reactive protein. J Clin Gastroenterol. 1994;19:112-117.
28. Pezzilli R, Billi P, Gullo L, et al. Behavior of serum soluble interleukin-2 receptor, soluble CD8 and soluble CD4 in the early phases of acute pancreatitis. Digestion. 1994;55:268-273.
29. Pezzilli R, Melzi d'Eril GV, Morselli-Labate AM, et al. Serum amyloid A, procalcitonin, and C-reactive protein in early assessment of severity of acute pancreatitis. Dig Dis Sci. 2000;45:1072-1078.
30. Pezzilli R, Morselli-Labate AM, Barakat B, et al. Is the association of serum lipase with beta2-microglobulin or C-reactive protein useful for establishing the diagnosis and prognosis of patients with acute pancreatitis? Clin Chem Lab Med. 1998;36:963-967.
31. Pezzilli R, Morselli-Labate AM, Miniero R, et al. Simultaneous serum assays of lipase and interleukin-6 for early diagnosis and prognosis of acute pancreatitis. Clin Chem. 1999;45:1762-1767.
32. Appelros S, Petersson U, Toh S, et al. Activation peptide of carboxypeptidase B and anionic trypsinogen as early predictors of the severity of acute pancreatitis. Br J Surg. 2001;88:216-221.
33. Otani T, Chepilko SM, Grendell JH, et al. Codistribution of TAP and the granule membrane protein GRAMP-92 in rat caerulein-induced pancreatitis. Am J Physiol. 1998;275:G999-G1009.
34. Sandberg AA, Borgstrom A. Early prediction of severity in acute pancreatitis. Is this possible? JOP. 2002;3:116-125.
35. Heath DI, Wilson C, Gudgeon AM, et al. Trypsinogen activation peptides (TAP) concentrations in the peritoneal fluid of patients with acute pancreatitis and their relation to the presence of histologically confirmed pancreatic necrosis. Gut. 1994;35:1311-1315.
36. Tenner S, Fernandez-del Castillo C, Warshaw A, et al. Urinary trypsinogen activation peptide (TAP) predicts severity in patients with acute pancreatitis. Int J Pancreatol. 1997;21:105-110.
37. Wang Y, Naruse S, Kitagawa M, et al. Urinary excretion of trypsinogen activation peptide (TAP) in taurocholate-induced pancreatitis in rats. Pancreas. 2001;22:24-27.
38. Neoptolemos JP, Kemppainen EA, Mayer JM, et al. Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study. Lancet. 2000;355:1955-1960.
39. Khan Z, Vlodov J, Horovitz J, et al. Urinary trypsinogen activation peptide is more accurate than hematocrit in determining severity in patients with acute pancreatitis: a prospective study. Am J Gastroenterol. 2002;97:1973-1977.
40. Lempinen M, Stenman UH, Finne P, et al. Trypsinogen-2 and trypsinogen activation peptide (TAP) in urine of patients with acute pancreatitis. J Surg Res. 2003;15:267-273.
41. Pezzilli R, Billi P, Migliori M, et al. Clinical value of pancreatitis-associated protein in acute pancreatitis. Am J Gastroenterol. 1997;92:1887-1890.
42. Banks PA, Carr-Locke DL, Slivka A, et al. Urinary trypsinogen activation peptides (TAP) are not increased in mild ERCP-induced pancreatitis. Pancreas. 1996;12:294-297.
43. Conn M, Goldenberg A, Concepcion L, et al. The effect of ERCP on circulating pancreatic enzymes and pancreatic protease inhibitors. Am J Gastroenterol. 1991;86:1011-1014.
44. Kemppainen E, Hedstrom J, Puolakkainen P, et al. Increased serum trypsinogen 2 and trypsin 2-alpha 1 antitrypsin complex values identify endoscopic retrograde cholangiopancreatography induced pancreatitis with high accuracy. Gut. 1997;41:690-695.
45. Simpson KW, Beechey-Newman N, Lamb CR, et al. Cholecystokinin-8 induces edematous pancreatitis in dogs associated with short burst of trypsinogen activation. Dig Dis Sci. 1995;40:2152-2161.
46. Levitt MD, Eckfeldt JH. Diagnosis of acute pancreatitis. In: Go VLW, DiMagno EP, Gardner JD, et al., eds. The Pancreas: Biology, Pathobiology and Disease, 2nd ed. New York: Raven Press; 1993:613-635.
47. Foitzik T, Hotz HG, Schmidt J, et al. Effect of microcirculatory perfusion on distribution of trypsinogen activation peptides in acute experimental pancreatitis. Dig Dis Sci. 1995;40:2184-2188.
48. Fernandez-del Castillo C, Schmidt J, Rattner DW, et al. Generation and possible significance of trypsinogen activation peptides in experimental acute pancreatitis in the rat. Pancreas. 1992;7:263-270.
49. Schmidt J, Fernandez-del Castillo C, Rattner DW, et al. Trypsinogen-activation peptides in experimental rat pancreatitis: prognostic implications and histopathologic correlates. Gastroenterology. 1992;103:1009-1016.
50. Karanjia ND, Widdison AL, Jehanli A, et al. Assay of trypsinogen activation in the cat experimental model of acute pancreatitis. Pancreas. 1993;8:189-195.